Evidence map›Paper›PMID 17033691›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2007

Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms.

Hwa Kyoung Shin, Salvatore Salomone, E Michelle Potts, Sae-Won Lee, Eric Millican, Kensuke Noma, Paul L Huang, David A Boas, James K Liao, Michael A Moskowitz and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. The Roles of RhoA/ROCK/NF-κB Pathway in Microglia Polarization Following Ischemic Stroke.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hwa Kyoung ShinDepartment of Radiology, Stroke and Neurovascular Regulation Laboratory, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA.
Salvatore Salomone
E Michelle Potts
Sae-Won Lee
Eric Millican
Kensuke Noma
Paul L Huang
David A Boas
James K Liao
Michael A Moskowitz
Cenk Ayata
Harvard University · USMassachusetts General Hospital · US

Funding

TRIGEMINAL NERVE--CONTROL OF THE BRAIN VASCULATUREP01NS035611 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI SORENSEN, A. GREGORY · 1996 to 2011
$15.4M
Spatiotemporal Brain Imaging: Microscopic &System LevelR01EB000790 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DALE, ANDERS M · 2002 to 2015
$15.3M
TRIGEMINOVASCULAR CONTROL OF CEREBRAL BLOOD VESSELSP50NS010828 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1985 to 2007
$10.8M
LIPOPROTEINS EFFECTS ON G PROTEIN FUNCTIONR01HL052233 · NHLBI · UNIVERSITY OF CHICAGO · PI LIAO, JAMES KUANG-JAN · 1995 to 2016
$5.3M
REGULATION OF CEREBRAL BLOOD FLOWR01NS033335 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI HUANG, PAUL L. · 1994 to 2012
$4.2M
Activation of eNOS by Steroid HormonesR01HL070274 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIAO, JAMES KUANG-JAN · 2002 to 2006
$2.2M
Role of PI3-Kinase in Estrogen-induced eNOS ActivationR01DK062729 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI LIAO, JAMES KUANG-JAN · 2003 to 2007
$1.9M
NITRIC OXIDE SYNTHASE ISOFORMS IN ATHEROSCLEROSISR01HL057818 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HUANG, PAUL L. · 1998 to 2006
$1.8M
Endothelial Akt in Vascular InjuryR01HL080187 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIAO, JAMES KUANG-JAN · 2006 to 2009
$1.6M
Role of protein kinase Akt in cerebral ischemiaP01NS010828 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MOSKOWITZ, MICHAEL A. · 1989 to 2008
$1.4M
ATHEROSCLEROSIS AND CEREBRAL ISCHEMIAR01NS048426 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI HUANG, PAUL L. · 2004 to 2008
$974k
NHLBI NIH HHS R01 HL052233NHLBI NIH HHS R01 HL057818NHLBI NIH HHS R01 HL070274NHLBI NIH HHS R01 HL080187NIBIB NIH HHS R01 EB000790NIBIB NIH HHS R01EB00790-01A2NIDDK NIH HHS R01 DK062729NINDS NIH HHS P01 NS010828NINDS NIH HHS P01 NS035611NINDS NIH HHS P01 NS35611NINDS NIH HHS P50 NS010828NINDS NIH HHS P50 NS10828NINDS NIH HHS R01 NS033335NINDS NIH HHS R01 NS048426
6 · The paper itself

Abstract

Rho-kinase is a serine threonine kinase that increases vasomotor tone via its effects on both endothelium and smooth muscle. Rho-kinase inhibition reduces cerebral infarct size in wild type, but not endothelial nitric oxide synthase deficient (eNOS-/-) mice. The mechanism may be related to Rho-kinase activation under hypoxic/ischemic conditions and impaired vasodilation because of downregulation of eNOS activity. To further implicate Rho-kinase in impaired vascular relaxation during hypoxia/ischemia, we exposed isolated vessels from rat and mouse to 60 mins of hypoxia, and showed that hypoxia reversibly abolished acetylcholine-induced eNOS-dependent relaxation, and that Rho-kinase inhibitor hydroxyfasudil partially preserved this relaxation during hypoxia. We, therefore, hypothesized that if hypoxia-induced Rho-kinase activation acutely impairs vasodilation in ischemic cortex, in vivo, then Rho-kinase inhibitors would acutely augment cerebral blood flow (CBF) as a mechanism by which they reduce infarct size. To test this, we studied the acute cerebral hemodynamic effects of Rho-kinase inhibitors in ischemic core and penumbra during distal middle cerebral artery occlusion (dMCAO) in wild-type and eNOS-/- mice using laser speckle flowmetry. When administered 60 mins before or immediately after dMCAO, Rho-kinase inhibitors hydroxyfasudil and Y-27632 reduced the area of severely ischemic cortex. However, hydroxyfasudil did not reduce the area of CBF deficit in eNOS-/- mice, suggesting that its effect on CBF within the ischemic cortex is primarily endothelium-dependent, and not mediated by its direct vasodilator effect on vascular smooth muscle. Our results suggest that Rho-kinase negatively regulates eNOS activity in acutely ischemic brain, thereby worsening the CBF deficit. Therefore, rapid nontranscriptional upregulation of eNOS activity by small molecule inhibitors of Rho-kinase may be a viable therapeutic approach in acute stroke.

Indexed as

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAcetylcholineAnimalsBrain IschemiaCerebrovascular CirculationDown-RegulationEndothelium, VascularEnzyme InhibitorsHypoxia, BrainInfarction, Middle Cerebral ArteryIntracellular Signaling Peptides and ProteinsLaser-Doppler FlowmetryMiceMice, Inbred C57BLMice, KnockoutNG-Nitroarginine Methyl Ester1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAcetylcholineEnzyme InhibitorshydroxyfasudilIntracellular Signaling Peptides and ProteinsNG-Nitroarginine Methyl EsterNitric Oxide Synthase Type IIIProtein Serine-Threonine Kinasesrho-Associated KinasesVasodilator Agents

Identifiers

PMID17033691
PMCPMC2614438
OpenAlexW2101100259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.